NI-205

N/A

Report date: 2022/12/15 16:24:42

Base Information

Drug NameNI-205
Drug Alias NameNI-205
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody fragment > Single-chain FV antibody fragment (scFv)
Mechanisms of ActionTAR DNA binding protein 43 inhibitors
TargetsTAR DNA binding protein 43
Therapy Area/IndicationsAmyotrophic Lateral SclerosisFrontotemporal Dementia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNeurimmune AgBiogen Inc
China Registration ClassN/A

Develop Information

Active CompaniesBiogen IncNeurimmune Ag
Inactive CompaniesN/A
Active IndicationsAmyotrophic Lateral SclerosisFrontotemporal Dementia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A